Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-79

I was having a look at the options yesterday thinking it's not a bad way of getting exposure.

I sold about 70% of my shares at prices between 40 cents and 30 cents on the way down. Took a massive hit, as I was overexposed to this company (my fault) and now hold enough if it gets back to $3.85 I break even.

Like many others, lost any confidence or belief in the company and in particular PR. I find my greed gene being aroused once again after the recent updates and talk of deals, etc., but will run with what I have as once bitten......

GLTA, especially those continuing to buy. With 98% probability of success in P3, this decision from FDA really is a company maker.